UA Cancer Center team targets tumor suppressor to treat 'triple-negative' breast cancer

(University of Arizona Health Sciences) A team led by UA Cancer Center researchers Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, screened for drugs that could target triple-negative breast cancer tumors, producing several new therapeutic candidates for this difficult-to-treat cancer.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

BREAST cancer symptoms begin to appear when cells grow and divide uncontrollably in this area. You should check your whole breast regularly for any warning sign of breast cancer. Watch out for these three signs of the condition.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
This review highlights evidence from recent practice-changing clinical trials on new approaches to sentinel lymph node biopsy and axillary lymph node dissection in breast cancer patients.American Journal of Clinical Pathology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Magnetic nanoparticle-aided microwave imaging is recently gaining an increasing interest as a potential tool for breast cancer diagnostics. This is due to the peculiar features of magnetic nanoparticles, which are biocompatible, can be selectively targeted to the tumor, and may change their microwave magnetic response when modulated by a polarizing magnetic field. This latter aspect is particularly appealing, as it enables the physical separation of the microwave signal due the malignancy, targeted by the nanoparticles, from that due to healthy tissue. This increases the specificity of the diagnostic tool, in principle all...
Source: IEEE Transactions on Biomedical Engineering - Category: Biomedical Engineering Source Type: research
While 96 per cent of patients aged 50 to 69 have surgery to remove tumours, this falls to 76 per cent for those over 70.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
New J. Chem., 2018, Advance Article DOI: 10.1039/C8NJ01713A, PaperTania Lozano-Cruz, Rafael Gomez, F. Javier de la Mata, Paula Ortega A water soluble "bow-tie" cationic carbosilane dendrimer with curcumin in the core displays antioxidant and antitumoral activities against breast cancer cells. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - New J. Chem. latest articles - Category: Chemistry Authors: Source Type: research
Abstract Transfeminine individuals are treated with estradiol and anti-androgen agents to transition to a more feminine appearance. The physical changes that occur with estradiol therapy include breast development, body fat redistribution, and decreased muscle mass. Transfeminine treatment regimens require monitoring and dose adjustments to achieve appropriate physiologic targets to enhance feminization and decrease risk of adverse outcomes. Adverse effects associated with estradiol use include thromboembolic disease, macroprolactinoma, breast cancer, coronary artery disease, cerebrovascular disease, cholelithiasi...
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Clin Plast Surg Source Type: research
Buried in a new N.I.H. report are disturbing examples of coordination between scientists and the alcohol industry on a study that could have changed America ’ s drinking habits.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Alcoholic Beverages Clinical Trials Alcohol Abuse Breast Cancer Heart Liquor National Institutes of Health Collins, Francis S Source Type: news
Researchers have developed a quicker, better and cheaper way than mammograms to detect breast cancer: a laser scanner that can find tumors in 15 seconds.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
Condition:   Breast Cancer Interventions:   Drug: ZN-c5;   Drug: Palbociclib Sponsor:   Zeno Alpha Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer, Invasive Ductal Intervention:   Device: Philips Sonalleve® MR-HIFU Breast Therapy System Sponsor:   Kantonsspital Winterthur KSW Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology